We are live on
!
Find out more
GA
GuoLine Advisory Portfolio holdings
AUM
$1.07B
1-Year Est. Return
26.27%
This Fund
S&P 500
This Quarter
Est. Return
+1.53%
1 Year Est. Return
+26.27%
3 Year Est. Return
+81.88%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$969M
AUM Growth
-$12.8M
(-1.3%)
Cap. Flow
-$11.5M
Cap. Flow
% of AUM
-1.19%
Top 10 Holdings %
Top 10 Hldgs %
66.62%
Holding
21
New
–
Increased
2
Reduced
3
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$12M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$6.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palo Alto Networks
PANW
|
+$13.1M |
| 2 |
CrowdStrike
CRWD
|
+$9.48M |
| 3 |
ServiceNow
NOW
|
+$7.29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 43.08% |
| 2 | Healthcare | 20.68% |
| 3 | Financials | 20.09% |
| 4 | Communication Services | 9.69% |
| 5 | Consumer Discretionary | 6.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.45T
| $102M | 10.48% |
240,900
| – | – |
|
2
Alphabet (Google) Class A
GOOGL
$4.36T
| $93.9M | 9.69% |
496,000
| – | – |
|
3
Apple
AAPL
$4.54T
| $93.1M | 9.6% |
371,700
| – | – |
|
4
Amazon
AMZN
$2.92T
| $62.7M | 6.47% |
285,680
| – | – |
|
5
Mastercard
MA
$502B
| $59.5M | 6.14% |
113,000
| – | – |
|
6
Visa
V
$684B
| $56.9M | 5.87% |
180,000
| – | – |
|
7
Thermo Fisher Scientific
TMO
$213B
| $46.8M | 4.83% |
90,000
| – | – |
|
|
8
ServiceNow
NOW
$115B
| $46.3M | 4.77% |
218,250
-36,000
| -14% | -$7.29M |
|
9
S&P Global
SPGI
$121B
| $45.5M | 4.7% |
91,400
| – | – |
|
10
Salesforce
CRM
$151B
| $39.4M | 4.07% |
117,890
| – | – |
|
11
Zscaler
ZS
$24.5B
| $34.5M | 3.56% |
191,060
| – | – |
|
12
KLA
KLAC
$239B
| $33.1M | 3.41% |
525,000
| – | – |
|
|
13
Regeneron Pharmaceuticals
REGN
$78.5B
| $33M | 3.41% |
46,360
+14,300
| +45% | +$12M |
|
14
Arthur J. Gallagher & Co
AJG
$64.1B
| $32.8M | 3.38% |
115,400
| – | – |
|
15
Vertex Pharmaceuticals
VRTX
$121B
| $32.1M | 3.31% |
79,700
| – | – |
|
16
GE HealthCare
GEHC
$30.7B
| $30.3M | 3.12% |
387,100
| – | – |
|
|
NVO
17
Novo Nordisk
NVO
$208B
| $29.8M | 3.08% |
346,500
+58,900
| +20% | +$6.37M |
|
18
Zoetis
ZTS
$32.4B
| $28.4M | 2.93% |
174,400
| – | – |
|
19
Adobe
ADBE
$99.5B
| $26.7M | 2.75% |
60,020
| – | – |
|
|
20
Palo Alto Networks
PANW
$270B
| $24.6M | 2.54% |
135,200
-69,600
| -34% | -$13.1M |
|
|
21
CrowdStrike
CRWD
$194B
| $18.3M | 1.89% |
214,400
-114,000
| -35% | -$9.48M |
|
Similar funds
SCM
PP
DCP
ZIG
EC
FNT
TAM
EG
GuoLine Advisory's Q4 2024 Portfolio in Review
As of Q4 2024, GuoLine Advisory held 21 positions worth $969M, down 1.3% from $982M the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 0%. GuoLine Advisory opened no new positions and made no exits, leaving the 21-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 43% of assets, down from 44% a quarter earlier, followed by Healthcare and Financials.
- GuoLine Advisory added most to Regeneron Pharmaceuticals in Q4 2024, an estimated $12M increase.
- GuoLine Advisory's biggest Q4 2024 reduction was Palo Alto Networks, cutting an estimated $13.1M.
- GuoLine Advisory's ten largest holdings make up 67% of its $969M portfolio in Q4 2024.
- GuoLine Advisory opened 0 new positions and closed 0 in Q4 2024.
- GuoLine Advisory's portfolio value fell 1.3% quarter-over-quarter to $969M.
Based on GuoLine Advisory's 13F filing for Q4 2024, filed 14 Jan 2025.